• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Hemagglutinin Structures and Antibody Recognition

tetano

Editor, Senior Moderator
Cold Spring Harb Perspect Med. 2019 Dec 23. pii: a038778. doi: 10.1101/cshperspect.a038778. [Epub ahead of print] [h=1]Influenza Hemagglutinin Structures and Antibody Recognition.[/h]
Wu NC[SUP]1[/SUP], Wilson IA[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h] 1 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA. 2 The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA.

[h=3]Abstract[/h] Hemagglutinin (HA) is most abundant glycoprotein on the influenza virus surface. Influenza HA promotes viral entry by engaging the receptor and mediating virus-host membrane fusion. At the same time, HA is the major antigen of the influenza virus. HA antigenic shift can result in pandemics, whereas antigenic drift allows human circulating strains to escape herd immunity. Most antibody responses against HA are strain-specific. However, antibodies that have neutralizing activities against multiple strains or even subtypes have now been discovered and characterized. These broadly neutralizing antibodies (bnAbs) target conserved regions on HA, such as the receptor-binding site and the stem domain. Structural studies of such bnAbs have provided important insight into universal influenza vaccine and therapeutic design. This review discusses the HA functions as well as HA-antibody interactions from a structural perspective.
Copyright ? 2019 Cold Spring Harbor Laboratory Press; all rights reserved.


PMID: 31871236 DOI: 10.1101/cshperspect.a038778
 
Back
Top Bottom